Publication | Open Access

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial

Radiation TherapyRtog 0615MedicineMulti-institutional TrialCancer TreatmentPhase 2OncologyRadiation OncologyRadiologyHealth Sciences